1st May, 2025

Launch of Sugammadex 200 mg/2 ml Solution for injection

Bowmed Ibisqus is pleased to announce the launch of Sugammadex vials. The product is a 200mg/2ml dose presented in a 10-pack vial for intravenous administration as a single bolus injection. Sugammadex is a medication for the reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults and rocuronium in paediatric patients.

This new product line has been listed with AAH under code SUG0045C and stock is available for customers effective immediately.

The 500mg/5ml dose of this product will also follow later in 2025 and we will announce the launch in due course.

If you would like to discuss a pricing arrangement or stock availability for Sugammadex or any of our other products, please contact us directly on +44 (0)845 6436 703 or email us